Bioequivalence Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 200/6 microg/Inhalation and Symbicort Turbohaler 200 microg/6 microg/Inhalation.
Phase of Trial: Phase I/II
Latest Information Update: 17 Feb 2010
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Acronyms KINECO
- Sponsors Orion
- 17 Feb 2010 Actual end date (Feb 2010) and actual number of patients (87) added as reported by ClinicalTrials.gov.
- 17 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2009 New trial record